Chanda-Kapata P,Ntoumi F,Kapata N,Lungu P,Mucheleng'anga LA,Chakaya J .2022 .Tuberculosis, HIV/AIDS and Malaria health services in sub-Saharan Africa - a situation analysis of the disruption and impact of the COVID-19 pandemic. Int J Infect Dis, 03 : 541-6.
Moreno R,Ravasi G,Avedillo P,Lopez R .2020 .Tuberculosis and HIV coinfection and related collaborative activities in Latin America, the Caribbean. Rev Panam Salud Publica, 10 : .
Sekayi W,Namyalo E,Namayanja J,Kungu JM .2023 .Prevalence and predictors of tuberculosis among HIV patients who completed isoniazid preventive therapy (IPT) at Reach out Mbuya community health initiative. Sci Rep, 10(1) : 17602.
Ahmad SR,Yaacob NA,Jaeb MZ,Hussin Z,Health J Public .2020 .Effect of diabetes mellitus on tuberculosis treatment outcomes among tuberculosis patients in Kelantan, Malaysia. , 10(8) : 1485-93.
Zeru MA .2021 .Prevalence and associated factors of HIV-TB co-infection among HIV patients: a retrospective study. Afr Health Sci, 10(3) : 7-9.
Chijioke-Akaniro OO,Ubochioma E,Omoniyi A,Fashade O,Olarewaju O,Asuke S .2022 .Improving TB case notification and treatment coverage through data use. Public Health Action, 10(3) : 128-32.
Shrestha S,Mishra G,Hamal M,Dhital R,Shrestha S,Shrestha A .2023 .Quantifying the potential epidemiological impact of a 2-year active case finding for tuberculosis in rural Nepal: a model-based analysis. -062123, 10(11) : .
Wondmeneh TG,Mekonnen AT .2023 .The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis, 10(1) : 613.
Adesanya OA,Uche-Orji CI,Adedeji YA,Joshua JI,Adesola AA,Chukwudike CJ .2021 .Bacillus Calmette-Guerin (BCG): the adroit vaccine. AIMS Microbiol, 10(1) : 96-113.
Li J,Lu J,Wang G,Zhao A,Xu M .2022 .Past, present and future of bacillus Calmette-Guérin vaccine use in China. Vaccines (Basel), 10(7) : 1157.
Setiabudiawan TP,Reurink RK,Hill PC,Netea MG,van Crevel R,Koeken VACM .2021 .Protection against tuberculosis by Bacillus CalmetteGuérin (BCG) vaccination: a historical perspective. Med, 11(1) : 6-24.
Boualam A,Seghiri R,Touil D,Berrid N,Aouane EM .2023 .A crosssectional epidemiological study of tuberculosis in the province of Sidi Kacem, Morocco. Pan Afr Med, 44(1) : 106.
Villar-Hernández R,Ghodousi A,Konstantynovska O,Duarte R,Lange C,Raviglione M. Tuberculosis C .2023 .: current challenges and beyond. Breathe (Sheff), 10(1) : 0166-2022.
.2023 .. Global Tuberculosis Report, : .
Hamada Y,Getahun H,Tadesse BT,Ford N. .2021 .HIV-associated tuberculosis. Int J STD AIDS, 10(9) : 780-90.
Bayowa JR,Kalyango JN,Baluku JB,Katuramu R,Ssendikwanawa E,Zalwango JF .2023 .Mortality rate and associated factors among patients co-infected with drug resistant tuberculosis/HIV at Mulago National Referral Hospital, Uganda, a retrospective cohort study. PLOS Glob Public Health, 10(7) : .
Yang N,He J,Li J,Zhong Y,Song Y,Chen C .2023 .Predictors of death among TB/HIV co-infected patients on tuberculosis treatment in Sichuan, China: a retrospective cohort study. Medicine (Baltimore), 10(5) : .
Torpey K,Agyei-Nkansah A,Ogyiri L,Forson A,Lartey M,Ampofo W .2020 .Management of TB/HIV co-infection: the state of the evidence. Ghana Med, 10(3) : 10-96.
Pham BN,Abon N,Silas VD,Jorry R,Rao C,Okely T .2022 .Tuberculosis and HIV/AIDS-attributed mortalities and associated sociodemographic factors in Papua New Guinea: evidence from the comprehensive health and epidemiological surveillance system. -058962, 10(6) : .
Moyo E,Moyo P,Murewanhema G,Mhango M,Chitungo I,Dzinamarira T. .2023 .Key populations and Sub-Saharan Africa's HIV response. Front Public Health, 10 : 1079990.
Kaswa M,Minga G,Nkiere N,Mingiedi B,Eloko G,Nguhiu P .2021 .The economic burden of TB-affected households in DR Congo. Int J Tuberc Lung Dis, 10(11) : 923-32.
Faccin M,Rusumba O,Ushindi A,Riziki M,Habiragi T,Boutachkourt F .2022 .Data-driven identification of communities with high levels of tuberculosis infection in the Democratic Republic of Congo. Sci Rep, 10(1) : 3912.
Fari SE,Mouna M,Haja K,Jait N,Moussadik Y,Jaradat T .2023 .Resistant tuberculosis in HIV-positive patients: a growing public health threat. Am J Intern Med, 20231103(3) : 55-9.
Kandala NB,Mandungu TP,Mbela K,Nzita KPD,Kalambayi BB,Kayembe KP .2014 .Child mortality in the Democratic Republic of Congo: cross-sectional evidence of the effect of geographic location and prolonged conflict from a national household survey. BMC Public Health, 10 : 1471.
Bekker LG,Alleyne G,Baral S,Cepeda J,Daskalakis D,Dowdy D .2018 .Advancing global health and strengthening the HIV response in the era of the sustainable development goals: the international AIDS society-lancet commission. Lancet, 6736(18) : 31070-5.
Esmail A,Sabur NF,Okpechi I,Dheda K. .2018 .Management of drugresistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. J Thorac Dis, 10(5) : 3102-18.
Sossen B,Kubjane M,Meintjes G .2025 .Tuberculosis and HIV coinfection: progress and challenges towards reducing incidence and mortality. Int J Infect Dis, 10 : 107876.
Bongo G,Tuntufye H,Ngbolua KN,Malakalinga J,Tshiama C,Pambu A .2017 .Comparative anti-mycobacterial activity on LowensteinJensen slants of selected medicinal plants used in the Congolese pharmacopeia. J Dis Med Plants, 20170305(5) : 88-96.
Bongo GN,Tuntufye HN,Malakalinga J,Ngbolua KNN,Pambu AL,Tshiama C .2018 .Anti-mycobacterial activity on middlebrook 7H10 agar of selected Congolese medicinal plants. Biosci Bioeng, 4(5) : 68-77.
Wilson JW,Nilsen DM,Marks SM .2020 .Multidrug-resistant tuberculosis in patients with human immunodeficiency virus. management considerations within high-resourced settings. Ann Am Thorac Soc, 10(1) : 185CME-23.
Heidary M,Shirani M,Moradi M,Goudarzi M,Pouriran R,Rezaeian T .2021 .Tuberculosis challenges: resistance, co-infection, diagnosis, and treatment. Eur J Microbiol Immunol (Bp), 10(1) : 1-17.
Shah GH,Maluantesa L,Etheredge GD,Waterfield KC,Ikhile O,Beni R .2021 .HIV Viral suppression among people living with HIV on antiretroviral therapy in Haut-Katanga and Kinshasa provinces of democratic republic of Congo. Healthcare (Basel), 10(1) : 69.
Mukuku O,Mutombo AM,Kakisingi CN,Musung JM,Wembonyama SO,Luboya ON .2019 .Tuberculosis and HIV co-infection in Congolese children: risk factors of death. Pan Afr Med, 33 : 326.
.2023 .The Global Fund. port_report_en.pdf, 26 : .
Seid A,Girma Y,Abebe A,Dereb E,Kassa M,Berhane N. .2023 .Characteristics of TB/HIV Co-infection and patterns of multidrugresistance tuberculosis in the Northwest Amhara, Ethiopia. Infect Drug Resist, 10 : 3829-45.
García JI,Allué-Guardia A,Tampi RP,Restrepo BI,Torrelles JB .2021 .New developments and insights in the improvement of mycobacterium tuberculosis vaccines and diagnostics within the end TB strategy. Curr Epidemiol Rep, 10 : 33-45.
Palambwa AAR,Nsutier KO,Bongo GN,Nsobani LD,Amuli JJP .2019 .Risk Factors for Mortality in Patients with TB-HIV Co-Infection at the General Provincial Reference Hospital of Kinshasa. Arch Intern Med Res, 2 : 014-24.
Sultana ZZ,Hoque FU,Beyene J,Akhlak-Ul-Islam MD,Khan HR,Ahmed S .2021 .HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis, 10 : 51.
Jackson S,Kabir Z,Corniskey C. .2021 .Effects of migration on tuberculosis epidemiological indicators in low and medium tuberculosis incidence countries: a systematic review. J Clin Tuberc Other Mycobact Dis, 10 : 100225.
Pareek M,Greenaway C,Noori T,Munoz J,Zenner D. .2016 .The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med, 10 : 48.
Cerrone M,Bracchi M,Wasserman S,Pozniak A,Meintjes G,Cohen K .2020 .Safety implications of combined antiretroviral and antituberculosis drugs. Expert Opin Drug Saf, 10(1) : 23-41.
Feldman C,Theron AJ,Cholo MC,Anderson R .2024 .Cigarette smoking as a risk factor for tuberculosis in adults: epidemiology and aspects of disease pathogenesis. Pathogens, 10(2) : 151.
Quan DH,Kwong AJ,Hansbro PM,Britton WJ .2022 .No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. Eur Respir Rev, 10(164) : 0252-2021.
Todd H,Hudson M,Grolmusova N,Kazibwe J,Pearman J,Skender K .2023 .Social protection interventions for TB-affected households: a scoping review. Am J Trop Med Hyg, 10(4) : 0470-9.
Smith JP,Oeltmann JE,Hill AN,Tobias JL,Boyd R,Click ES .2022 .Characterizing tuberculosis transmission dynamics in high-burden urban and rural settings. Sci Rep, 10 : 6780.
Hunter RL .2020 .The Pathogenesis of tuberculosis-the Koch phenomenon reinstated. Pathogens, 10(10) : 813.
Tiwari D,Martineau AR .2022 .Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies. Semin Immunol, 10 : 101672.
Kaushik G,Vashishtha R,Verma C,Sharma S,Kumar V .2024 .Genetic variation in Toll-Like Receptors (TLRs) 2, 4, and 9 influences HIV disease progression toward active TB and AIDS. J Inflamm Res, 10 : 3283-91.
McLaren PJ,Fellay J .2021 .HIV-1 and human genetic variation. Nat Rev Genet, 10(10) : 645-57.
Izudi J,Okello G .2023 .Low treatment success rate among previously treated persons with drug-susceptible pulmonary tuberculosis in Kampala, Uganda. J Clin Tuberc Other Mycobact Dis, 10 : 100375.